On May 22, 2017, the Supreme Court issued a pivotal decision for purposes of venue in patent litigation, holding that the residence of a domestic corporation refers only to its State of incorporation. As such, legislative amendments which broadened the definition of corporate residence under the general venue statute, 28 U.S.C. §1391, do not modify the meaning of corporate residence under the patent venue statute, 28 U.S.C. §1400(b), as interpreted by Fourco Glass Co. v. Transmirra Products Corp., 353 U.S. 222 (1957). As a result, patent owners can no...Read Full Article >
On Monday, March 27, 2017, a Pennsylvania state judge declared a mistrial in the latest case over the alleged side effects of the Janssen Pharmaceuticals Inc. antipsychotic drug Risperdal. In the midst of his testimony, the expert witness for the plaintiff ran to the aid of a juror suffering a medical emergency. The expert, Dr. Mark Solomon, was to testify that the plaintiff’s exposure to Risperdal had caused him to develop large female-like breasts (a condition known as gynecomastia).
After the juror was taken to the hospital, Johnson &...Read Full Article >
Congratulations to our clients Bruce Baird, Ben Razi, Jon Dougherty, Andrew Leff and the rest of the Covington & Burling trial team in a rare defeat of the SDNY U.S. Attorney’s Office in a high-profile civil forfeiture case.
Following a seven day trial before Katherine Polk Failla, a Federal District of Manhattan jury reached a unanimous verdict in just three hours in favor of their client, Efans Trading Corporation. The government was seeking forfeiture of nearly $7 million in assets from Efans – including bank accounts and 47...Read Full Article >